Hologic Inc. Stock
Price
Target price
€71.00
€71.00
-2.080%
-1.5
-2.080%
€84.03
25.04.24 / Tradegate
WKN: 879100 / Symbol: HOLX / Name: Hologic / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Hologic Inc. Stock
A loss of -2.080% shows a downward development for Hologic Inc..
Hologic Inc. is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
As a result the target price of 84 € shows a slightly positive potential of 18.31% compared to the current price of 71.0 € for Hologic Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Hologic Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Hologic Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hologic Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hologic Inc. | -2.080% | 0.000% | 1.719% | -7.190% | 10.248% | 17.123% | 84.248% |
| QuidelOrtho Corp. | -3.660% | 2.778% | -15.487% | -54.668% | -45.444% | -61.410% | - |
| Boston Scientific | 0.000% | 7.874% | 10.341% | 46.933% | 33.165% | 93.996% | 108.049% |
| Illumina Inc. | -0.390% | 2.883% | -8.872% | -43.384% | -12.233% | -67.110% | -60.601% |
Comments
Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Show more
Ratings data for HOLX provided by MarketBeat
Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $95.00 price target on the stock, up previously from $80.00.
Show more
Ratings data for HOLX provided by MarketBeat
Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for HOLX provided by MarketBeat
News
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare
